CordenPharma Bergamo is a cGMP manufacturer of advanced pharmaceutical intermediates and APIs specializing in the design of synthetic routes and development processes for new products from laboratory to commercial scale, with equipment and chemical technologies that are particularly suitable for multi-step synthesis.

CordenPharma Bergamo brings over 40 years of experience and expertise in pharmaceutical chemistry, technology, project management and registration processes to CordenPharma’s full-service CMO platform.


  • 1962 Started by a private owner
  • 1979 First FDA Inspection
  • 1989 Facility purchased by Tessenderlo Group
  • 2012 Farchemia acquired by ICIG
  • 2016 Name changed to Corden Pharma Bergamo S.p.A.